Publications by authors named "Emma Bolam"

Claim this Profile
P
Production of a high purity, C-tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions.
Ekta Mukhopadhyay, Florian Brod, Philip Angell-Manning, Nicola Green, Richard D Tarrant, Emma J Bolam

Biotechnol Bioeng· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial.
Daniel Jenkin, Adam J Ritchie, Jeremy Aboagye, Sofiya Fedosyuk, Luke Thorley, Emma Bolam

Lancet Microbe· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production, quality control, stability, and potency of cGMP-produced RH5.1 protein vaccine expressed in S2 cells.
Jing Jin, Richard D Tarrant, Emma J Bolam, Philip Angell-Manning, Max Soegaard

NPJ Vaccines· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes.
Geoff Hale, Peppy Rebello, Ibrahim Al Bakir, Emma Bolam, Pawel Wiczling

J Clin Pharmacol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis